Table 1.
The correlation between MIOX protein expression and pathological and clinical features of 153 patients with ccRCC.
| Characteristics | MIOX expression |
||
|---|---|---|---|
| Low | High | p value | |
| Gender, n (%) | 0.906 | ||
| Male | 52 (68.4) | 52 (67.5) | |
| Female | 24 (31.6) | 25 (32.5) | |
| Age (y), median (range) | 58 (26–82) | 60 (29–82) | 0.472 |
| Grade, n (%) | 0.001 | ||
| 1 | 14 (18.4) | 17 (22.1) | |
| 2 | 28 (36.9) | 47 (61.0) | |
| 3 + 4 | 34 (44.7) | 13 (16.9) | |
| T stage, n (%) | 0.001 | ||
| T1 | 44 (57.9) | 65 (84.4) | |
| T2 | 13 (17.1) | 6 (7.8) | |
| T3+T4 | 19 (25.0) | 6 (7.8) | |
| N stage, n (%) | 0.988 | ||
| N0 | 73 (96.1) | 75 (97.4) | |
| N1 | 3 (3.9) | 2 (2.6) | |
| Distant metastasis, n (%) | 0.040 | ||
| M0 | 66 (86.8) | 74 (96.1) | |
| M1 | 10 (13.2) | 3 (3.9) | |